RxSight, Inc.·4

Feb 13, 6:19 PM ET

Kurtz Ronald M MD 4

4 · RxSight, Inc. · Filed Feb 13, 2023

Insider Transaction Report

Form 4
Period: 2023-02-10
Kurtz Ronald M MD
DirectorPresident & CEO
Transactions
  • Award

    Common Stock

    2023-02-10$12.50/sh+40,000$500,00040,000 total
Holdings
  • Common Stock

    (indirect: See footnore)
    929,610
Footnotes (2)
  • [F1]Includes 125,000 shares reported as directly held by the Reporting Person in previous Form 4 filings.
  • [F2]Shares held by Cricklewood LP. The Reporting Person is the manager of the general partner of Cricklewood LP and shares voting and investment control of the general partner of Cricklewood LP with his spouse.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION